phrykt

Moderna (MRNA) revenue: $1.9B

Moderna reported $1.9B of revenue for the year ended Dec 31, 2025, down 39.9% from $3.2B a year earlier.

From Moderna's filings with the SEC · Read the filing · MRNA stock page

Moderna revenue by year

$18.5B2021$19.3B2022$6.8B2023$3.2B2024$1.9B2025

#1,193 of 3,622 US companies by revenue · See the full ranking

Year endedRevenueChange
Dec 31, 2025$1.9B-40%
Dec 31, 2024$3.2B-53%
Dec 31, 2023$6.8B-64%
Dec 31, 2022$19.3B+4%
Dec 31, 2021$18.5B–

Revenue of similar companies

Companies in the same industry as Moderna, by SEC industry code, with the closest revenue. Each name opens the same page for that company.

CompanyRevenue, latest yearYear ended
Neurocrine Biosciences$2.9BDec 31, 2025
Exelixis$2.3BJan 2, 2026
Qiagen$2.1BDec 31, 2025
Moderna$1.9BDec 31, 2025
Halozyme Therapeutics$1.4BDec 31, 2025
BIO-TECHNE$1.2BJun 30, 2026
Novavax$1.1BDec 31, 2025

Questions and answers

What is Moderna's revenue?

Moderna reported $1.9B of revenue for the year ended Dec 31, 2025, down 39.9% from $3.2B a year earlier.

Numbers as reported in Moderna's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology